L De Schaepdrijver - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

L De Schaepdrijver

Showing results (11-20 of 13) with videos related to

Pageof 2

Sort By:

You have reached the last page of results.This site can display upto 13 results.

Therapeutic Innovation & Regulatory Science|September 21, 2018

Nonclinical Safety Considerations for the Development of Pediatric-First Drugs: An Industry ViewG Schmitt, J Ridings, L De Schaepdrijver, et al.

Pharmacological Reviews|February 20, 2021

Ontogeny of Hepatic Transporters and Drug-Metabolizing Enzymes in Humans and in Nonclinical SpeciesB D van Groen, J Nicolaï, A C Kuik, et al.

Therapeutic Innovation & Regulatory Science|April 5, 2016

Birth Control in Clinical Trials: Industry Survey of Current Use Practices, Governance, and MonitoringJ Stewart, W J Breslin, B K Beyer, et al.

Pageof 2

Search research articles

Showing results (11-20 of 13) with videos related to

Sort By:

Pageof 2

You have reached the last page of results.This site can display upto 13 results.

Therapeutic Innovation & Regulatory Science|September 21, 2018

Nonclinical Safety Considerations for the Development of Pediatric-First Drugs: An Industry ViewG Schmitt, J Ridings, L De Schaepdrijver, et al.

Pharmacological Reviews|February 20, 2021

Ontogeny of Hepatic Transporters and Drug-Metabolizing Enzymes in Humans and in Nonclinical SpeciesB D van Groen, J Nicolaï, A C Kuik, et al.

Therapeutic Innovation & Regulatory Science|April 5, 2016

Birth Control in Clinical Trials: Industry Survey of Current Use Practices, Governance, and MonitoringJ Stewart, W J Breslin, B K Beyer, et al.

Pageof 2